| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |